Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Zynerba Pharma CS (NQ: ZYNE )

3.555 USD -0.055 (-1.52%)
Official Closing Price Updated: 7:25 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Zynerba Pharma CS

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
First Week of ZYNE March 19th Options Trading
Investors in Zynerba Pharmaceuticals Inc (ZYNE) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences
From GlobeNewswire News Releases
First Week of ZYNE August 2021 Options Trading
Investors in Zynerba Pharmaceuticals Inc (ZYNE) saw new options become available this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is... 
Tags Stocks
From Market News Video
80 Biggest Movers From Yesterday
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 473.7% to close at $33.96 on Thursday. Scopus BioPharma’s ... 
Tags SQFT Health Care Movers
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers PainReform (NASDAQ:PRFX) stock increased by 41.55% to $6.23 during Thursday's regular session. ... 
Tags LIXT JAGX health care stocks
From Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 500% to $35.52. Scopus BioPharma’s filing showed registration ... 
Tags BCDA Trading Ideas RAD
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Seneca Biopharma (NASDAQ:SNCA) shares rose 49.4% to $1.16 during Thursday's pre-market session. The ... 
Tags Market News HJLI EOLS
From Benzinga
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CERE Small Cap RVMD
From Benzinga
Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome
From GlobeNewswire News Releases
Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
Immunome appoints Richard Baron to BOD and Sandra Stoneman as Chief Legal Officer and Corporate Secretary 
From Business Wire News Releases
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc. (ZYNE) 
From Business Wire News Releases
The Law Offices of Frank R. Cruz Announces Investigation of Zynerba Pharmaceuticals (ZYNE) on Behalf of Investors
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Zynerba Pharmaceuticals (“Zynerba” or the “Company”) (NASDAQ: ZYNE) concerning whether the board... 
From Business Wire News Releases
Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)
From GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the 2020 Virtual Annual Meeting of the American Epilepsy Society (AES)
From GlobeNewswire News Releases
The Week In Cannabis: Stocks Down Amid Earnings Season, Argentina Regulates Medical Marijuana
Cannabis stocks were back in the red this week, retreating from post-election highs amid an earnings-heavy period. Over the five ... 
Tags MJ CNPOF TGODF
From Benzinga
Earnings Update: Aurora, Canopy Growth, Canopy Rivers And Zynerba Each Post Results
Aurora Posts Q1 EBITDA Loss, ExpectsPositive EBITDA In Q2 Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) consolidated net ... 
Tags Canopy Rivers ACB Markets
From Benzinga
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
From GlobeNewswire News Releases
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th An
From GlobeNewswire News Releases
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Co
From GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting
From GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Virtual Joint 49th Annual Child Neurology Society & 16th International Child Neurology Society Congress (CNS-ICNA) Meeting
From GlobeNewswire News Releases
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Alphatec Holdings (NASDAQ:ATEC) stock rose 25.29% to $8.62 during Thursday's pre-market session. The company's ... 
Tags GOVX ZYNE Movers
From Benzinga
Legalization Efforts Continue to Drive the Cannabis Market Growth
FinancialBuzz.com News Commentary 
From PR Newswire
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome
From GlobeNewswire News Releases
Zynerba Pharmaceuticals Provides Update on Recent Milestones
From GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
From GlobeNewswire News Releases
The Pure US Cannabis ETF Started Trading Today: Here Are Its Holdings
The AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) started trading on Wednesday, becoming the first U.S.-listed active ETF focused ... 
Tags GRWG NBEV SSPK
From Benzinga
More People Turn to CBD as its List of Applications Grows
FinancialBuzz.com News Commentary 
From PR Newswire
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
From GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.